Addressing a significant need by describing the science and process involved to develop biosimilars of monoclonal antibody (mAb) drugs, this book covers all aspects of biosimilar development: preclinical, clinical, regulatory, manufacturing.
Traces the genesis and development of 'new music' throughout the twentieth century, deftly examining the social and political forces that shaped 'new music' and its uses by political activists and the government.